“Cognitive enhancement drugs only have short-term benefits and can cause significant side-effects for people with mild memory problems, according to researchers. In a new review of existing data, researchers at St. Michael’s Hospital in Toronto, Canada studied eight randomized clinical trials and three companion reports on the efficacy of four drugs in people with mild cognitive impairment. The drugs were donepezil (Aricept), rivastigmine (Exelon), galantamine (Razadyne), and memantine (Namenda). They found that while the drugs do have short-term benefits, they are lost after a year and a half of treatment.”
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin
Tip Freedomwat.ch Staff with Bitcoin
(Visited 24 times, 1 visits today)
Related posts:
Munich football boss's Swiss account becomes German political football
Spain museum uses robot to spot cracks in artwork
Some traders got Fed 'no taper' decision news early
Manchester officials nab five illegal taxis in sting operation
French competition watchdog raids Apple stores
Dept. of Agriculture approves horse slaughterhouse in New Mexico
Secrets, lies and Snowden's email: why I was forced to shut down Lavabit
If Apple Did What eBay Just Did, They'd Have A $44 Billion Tax Bill
Italy bans sale of electronic cigarettes to minors
From Walmart To Bitcoin: The CEO Behind The Chinese Exchange
Fund to Let Investors Bet on Price of Bitcoins
Americans’ personal data shared with CIA, IRS, others in security probe
Body cam shows dad had hands up when cops killed his 6-year-old son
Seeking cheap stocks, chaos no problem? Try Libya
Global Debt Exceeds $100 Trillion as Governments Binge, BIS Says